About Us
|
contact Us
|
Sitemap
Call us: +1-855-455-8662
|
Home
Business Solutions
Business Research Reports
Business Consulting
On-site Implementation & Training Programs
Industry Trackers
Subscription Solutions
Industry Reports
News
Press
Login
Register
Home
Market Research
Pneumococcal Vaccines Market Expected to Grow at 5.1% by 2029
Pneumococcal Vaccines Market By Vaccine (Pneumococcal Conjugate Vaccine, Pneumococcal Polysaccharide Vaccine), By Product (10-Valent PCV, 13-valent PCV, 23-valent PPSV) - Growth, Future Prospects & Competitive Analysis, 2021 - 2029
11 Dec 2018
Format
Request Sample
Report Summary
Table of contents
list of tables
list of figures
1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted
2. Executive Summary
2.1. Market Snapshot: Global Pneumococcal Vaccines Market
2.2. Global Pneumococcal Vaccines Market, By Vaccine, 2023 (US$ Million)
2.3. Global Pneumococcal Vaccines Market, By Product, 2023 (US$ Million)
2.4. Global Pneumococcal Vaccines Market, By Geography, 2023 (US$ Million)
2.5. Attractive Investment Proposition by Geography, 2023
3. Pneumococcal Vaccines Market: Competitive Analysis
3.1. Market Positioning of Key Pneumococcal Vaccines Market Vendors
3.2. Strategies Adopted by Pneumococcal Vaccines Market Vendors
3.3. Key Industry Strategies
3.4. Tier Analysis 2023 Versus 2032
4. Pneumococcal Vaccines Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Pneumococcal Vaccines Market Value, 2022 - 2032, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
4.6. Porter's Five Force Model
4.6.1. Supplier Power
4.6.2. Buyer Power
4.6.3. Threat Of Substitutes
4.6.4. Threat Of New Entrants
4.6.5. Competitive Rivalry
4.7. PESTEL Analysis
4.7.1. Political Landscape
4.7.2. Economic Landscape
4.7.3. Technology Landscape
4.7.4. Legal Landscape
4.7.5. Social Landscape
5. Pneumococcal Vaccines Market: By Vaccine, 2022-2032, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2023 Versus 2032
5.3. Market Segmentation
5.3.1. Pneumococcal Conjugate Vaccine
5.3.2. Pneumococcal Polysaccharide Vaccine
6. Pneumococcal Vaccines Market: By Product, 2022-2032, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2023 Versus 2032
6.3. Market Segmentation
6.3.1. 10-valent PCV
6.3.2. 13-valent PCV
6.3.3. 23-valent PPSV
6.3.4. Pipeline Analysis
6.3.4.1. Phase III Analysis
6.3.4.1.1. 15-valent PCV
6.3.4.1.2. 20-valent PCV
6.3.4.2. Tabular Representation of Phase I and Phase II Vaccines
7. North America Pneumococcal Vaccines Market, 2022-2032, USD (Million)
7.1. Market Overview
7.2. Pneumococcal Vaccines Market: By Vaccine, 2022-2032, USD (Million)
7.3. Pneumococcal Vaccines Market: By Product, 2022-2032, USD (Million)
7.4.Pneumococcal Vaccines Market: By Region, 2022-2032, USD (Million)
7.4.1.North America
7.4.1.1. U.S.
7.4.1.1.1. Pneumococcal Vaccines Market: By Vaccine, 2022-2032, USD (Million)
7.4.1.1.2. Pneumococcal Vaccines Market: By Product, 2022-2032, USD (Million)
7.4.1.2. Canada
7.4.1.2.1. Pneumococcal Vaccines Market: By Vaccine, 2022-2032, USD (Million)
7.4.1.2.2. Pneumococcal Vaccines Market: By Product, 2022-2032, USD (Million)
7.4.1.3. Rest of North America
7.4.1.3.1. Pneumococcal Vaccines Market: By Vaccine, 2022-2032, USD (Million)
7.4.1.3.2. Pneumococcal Vaccines Market: By Product, 2022-2032, USD (Million)
8. UK and European Union Pneumococcal Vaccines Market, 2022-2032, USD (Million)
8.1. Market Overview
8.2. Pneumococcal Vaccines Market: By Vaccine, 2022-2032, USD (Million)
8.3. Pneumococcal Vaccines Market: By Product, 2022-2032, USD (Million)
8.4.Pneumococcal Vaccines Market: By Region, 2022-2032, USD (Million)
8.4.1.UK and European Union
8.4.1.1. UK
8.4.1.1.1. Pneumococcal Vaccines Market: By Vaccine, 2022-2032, USD (Million)
8.4.1.1.2. Pneumococcal Vaccines Market: By Product, 2022-2032, USD (Million)
8.4.1.2. Germany
8.4.1.2.1. Pneumococcal Vaccines Market: By Vaccine, 2022-2032, USD (Million)
8.4.1.2.2. Pneumococcal Vaccines Market: By Product, 2022-2032, USD (Million)
8.4.1.3. Spain
8.4.1.3.1. Pneumococcal Vaccines Market: By Vaccine, 2022-2032, USD (Million)
8.4.1.3.2. Pneumococcal Vaccines Market: By Product, 2022-2032, USD (Million)
8.4.1.4. Italy
8.4.1.4.1. Pneumococcal Vaccines Market: By Vaccine, 2022-2032, USD (Million)
8.4.1.4.2. Pneumococcal Vaccines Market: By Product, 2022-2032, USD (Million)
8.4.1.5. France
8.4.1.5.1. Pneumococcal Vaccines Market: By Vaccine, 2022-2032, USD (Million)
8.4.1.5.2. Pneumococcal Vaccines Market: By Product, 2022-2032, USD (Million)
8.4.1.6. Rest of Europe
8.4.1.6.1. Pneumococcal Vaccines Market: By Vaccine, 2022-2032, USD (Million)
8.4.1.6.2. Pneumococcal Vaccines Market: By Product, 2022-2032, USD (Million)
9. Asia Pacific Pneumococcal Vaccines Market, 2022-2032, USD (Million)
9.1. Market Overview
9.2. Pneumococcal Vaccines Market: By Vaccine, 2022-2032, USD (Million)
9.3. Pneumococcal Vaccines Market: By Product, 2022-2032, USD (Million)
9.4.Pneumococcal Vaccines Market: By Region, 2022-2032, USD (Million)
9.4.1.Asia Pacific
9.4.1.1. China
9.4.1.1.1. Pneumococcal Vaccines Market: By Vaccine, 2022-2032, USD (Million)
9.4.1.1.2. Pneumococcal Vaccines Market: By Product, 2022-2032, USD (Million)
9.4.1.2. Japan
9.4.1.2.1. Pneumococcal Vaccines Market: By Vaccine, 2022-2032, USD (Million)
9.4.1.2.2. Pneumococcal Vaccines Market: By Product, 2022-2032, USD (Million)
9.4.1.3. India
9.4.1.3.1. Pneumococcal Vaccines Market: By Vaccine, 2022-2032, USD (Million)
9.4.1.3.2. Pneumococcal Vaccines Market: By Product, 2022-2032, USD (Million)
9.4.1.4. Australia
9.4.1.4.1. Pneumococcal Vaccines Market: By Vaccine, 2022-2032, USD (Million)
9.4.1.4.2. Pneumococcal Vaccines Market: By Product, 2022-2032, USD (Million)
9.4.1.5. South Korea
9.4.1.5.1. Pneumococcal Vaccines Market: By Vaccine, 2022-2032, USD (Million)
9.4.1.5.2. Pneumococcal Vaccines Market: By Product, 2022-2032, USD (Million)
9.4.1.6. Rest of Asia Pacific
9.4.1.6.1. Pneumococcal Vaccines Market: By Vaccine, 2022-2032, USD (Million)
9.4.1.6.2. Pneumococcal Vaccines Market: By Product, 2022-2032, USD (Million)
10. Latin America Pneumococcal Vaccines Market, 2022-2032, USD (Million)
10.1. Market Overview
10.2. Pneumococcal Vaccines Market: By Vaccine, 2022-2032, USD (Million)
10.3. Pneumococcal Vaccines Market: By Product, 2022-2032, USD (Million)
10.4.Pneumococcal Vaccines Market: By Region, 2022-2032, USD (Million)
10.4.1.Latin America
10.4.1.1. Brazil
10.4.1.1.1. Pneumococcal Vaccines Market: By Vaccine, 2022-2032, USD (Million)
10.4.1.1.2. Pneumococcal Vaccines Market: By Product, 2022-2032, USD (Million)
10.4.1.2. Mexico
10.4.1.2.1. Pneumococcal Vaccines Market: By Vaccine, 2022-2032, USD (Million)
10.4.1.2.2. Pneumococcal Vaccines Market: By Product, 2022-2032, USD (Million)
10.4.1.3. Rest of Latin America
10.4.1.3.1. Pneumococcal Vaccines Market: By Vaccine, 2022-2032, USD (Million)
10.4.1.3.2. Pneumococcal Vaccines Market: By Product, 2022-2032, USD (Million)
11. Middle East and Africa Pneumococcal Vaccines Market, 2022-2032, USD (Million)
11.1. Market Overview
11.2. Pneumococcal Vaccines Market: By Vaccine, 2022-2032, USD (Million)
11.3. Pneumococcal Vaccines Market: By Product, 2022-2032, USD (Million)
11.4.Pneumococcal Vaccines Market: By Region, 2022-2032, USD (Million)
11.4.1.Middle East and Africa
11.4.1.1. GCC
11.4.1.1.1. Pneumococcal Vaccines Market: By Vaccine, 2022-2032, USD (Million)
11.4.1.1.2. Pneumococcal Vaccines Market: By Product, 2022-2032, USD (Million)
11.4.1.2. Africa
11.4.1.2.1. Pneumococcal Vaccines Market: By Vaccine, 2022-2032, USD (Million)
11.4.1.2.2. Pneumococcal Vaccines Market: By Product, 2022-2032, USD (Million)
11.4.1.3. Rest of Middle East and Africa
11.4.1.3.1. Pneumococcal Vaccines Market: By Vaccine, 2022-2032, USD (Million)
11.4.1.3.2. Pneumococcal Vaccines Market: By Product, 2022-2032, USD (Million)
12. Company Profile
12.1. Pfizer, Inc.
12.1.1. Company Overview
12.1.2. Financial Performance
12.1.3. Product Portfolio
12.1.4. Strategic Initiatives
12.2. GlaxoSmithKline PLC
12.2.1. Company Overview
12.2.2. Financial Performance
12.2.3. Product Portfolio
12.2.4. Strategic Initiatives
12.3. Merck & Co., Inc.
12.3.1. Company Overview
12.3.2. Financial Performance
12.3.3. Product Portfolio
12.3.4. Strategic Initiatives
Choose Licence Type
Single User Licence
$4325
Multi User license
$6325
Corporate license
$12650
Buy Now
Quick Contact
+1-855-455-8662
+91 77559-81103
sales@acutemarketreports.com
View Other Reports
Automotive
986
Chemicals and Materials
684
Consumer Goods
184
Energy
124
Food & Beverages
321
Medical Devices
178
Pharmaceutical & Healthcare
78
Technology
234